( NASDAQ-SMALL:CTSO )

News from CytoSorbents Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 22, 2017, 07:15 ET Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Mar 20, 2017, 07:30 ET CytoSorb® Treatment of HLH - The Parallel to Cytokine Release Syndrome in Cancer Immunotherapy

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Mar 16, 2017, 07:00 ET CytoSorbents Announces CytoSorb® Partnership with Dr. Reddy's Laboratories

CytoSorbents Corporation (NASDAQ: CTSO), manufacturer of the CytoSorb® extracorporeal blood purification therapy that reduces excessive levels of...


Mar 07, 2017, 08:00 ET CytoSorbents Highlights Activities at the 22nd International Conference on Advances in Critical Care Nephrology

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Mar 06, 2017, 07:00 ET CytoSorbents to Present at the Maxim Group - Haitong Securities Inaugural Healthcare Investor and Partnering Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat...


Mar 03, 2017, 07:00 ET CytoSorbents Reports Record Quarterly and Full-Year 2016 Revenue

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to prevent or...


Mar 02, 2017, 07:00 ET CytoSorbents to Present at 37th Annual Cowen and Company Healthcare Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


Feb 24, 2017, 07:00 ET CytoSorbents to Report Fiscal 2016 Operating and Financial Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


Feb 07, 2017, 08:00 ET CytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


Jan 20, 2017, 09:00 ET CytoSorbents Launches VetResQ™ for U.S. Veterinary Market

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in...


Jan 11, 2017, 02:00 ET Fresenius Medical Care und CytoSorbents erweitern ursprüngliche Partnerschaft und fügen neue Co-Marketing-Vereinbarung für CytoSorb®-Märkte weltweit hinzu

Vereinbarung verstärkt Engagement mit 3-jähriger Verlängerung und garantierten CytoSorb-Mindestbestellmengen, und schafft gemeinsame...


Jan 11, 2017, 02:00 ET Fresenius Medical Care et CytoSorbents élargissent leur partenariat initial et ajoutent un nouvel accord de co-marketing pour les marchés CytoSorb® à l'échelle mondiale

L'accord renforce leur engagement avec un renouvellement de 3 ans, des commandes minimum garanties de CytoSorb, et établit des initiatives de...


Jan 11, 2017, 02:00 ET Fresenius Medical Care y CytoSorbents firman un nuevo acuerdo de marketing para CytoSorb®

- Fresenius Medical Care y CytoSorbents expanden su asociación original y firman un nuevo acuerdo de marketing conjunto para los mercados...


Jan 10, 2017, 09:00 ET CytoSorbents Pre-announces Q4 2016 and Full-Year 2016 Results

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Jan 09, 2017, 08:00 ET Fresenius Medical Care and CytoSorbents Expand Original Partnership and Add New Co-Marketing Agreement for Worldwide CytoSorb® Markets

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood adsorber to treat deadly...


Jan 03, 2017, 09:00 ET CytoSorbents To Provide Corporate Update at Biotech Showcase 2017

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 20, 2016, 08:00 ET CytoSorbents Announces First Sales of New CytoSorb® CPB Procedure Pack for Cardiac Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 12, 2016, 09:22 ET CytoSorbents Receives $318,551 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® blood filter to treat deadly...


Dec 07, 2016, 07:00 ET CytoSorb® Attains Permanent, Dedicated Reimbursement Code in Core Market of Germany

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification therapy to treat...


Dec 02, 2016, 08:00 ET CytoSorbents to Present at the LD Micro Main Event Investor Conference

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Dec 01, 2016, 07:15 ET CytoSorb® Selected for NICE MedTech Innovation Briefing in the United Kingdom

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 22, 2016, 08:20 ET First Successful Treatment of Dengue Fever and Dengue Shock Syndrome Using CytoSorb®

CytoSorbents Corporation (NASDAQ: CTSO), highlights the first successful treatment of Dengue Shock Syndrome caused by Dengue virus infection using...


Nov 17, 2016, 08:00 ET CytoSorbents Reports Highlights from the SepsEast 2016 Critical Care Congress

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 15, 2016, 08:00 ET Adrian Thomas Joins CytoSorbents to Drive Western European Sales

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its European Union approved CytoSorb® cytokine...


Nov 07, 2016, 16:15 ET CytoSorb® Q3 2016 Sales Reach Record $2.14M, Doubling From a Year Ago

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagship CytoSorb® cytokine adsorber to prevent...